Over 10,000 filings
Page 3 of 100
8-K
rdgz4t4a9ajps 98trcq
28 Mar 24
Entry into a Material Definitive Agreement
8:24am
8-K
tzm6jkz7nlhhrfkg bh
28 Mar 24
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
8:22am
8-K
b3p1n
28 Mar 24
Psychemedics Corporation Reports 2023 Financial Results
8:20am
8-K
v04x8b5vvgdewebz7on
28 Mar 24
Better Home & Finance Holding Company Announces Fourth Quarter and Full Year 2023 Results
8:19am
8-K
4fs70e 3ixfe82a739yl
28 Mar 24
Lowell Farms Inc. Announces Audited Fourth Quarter and Fiscal Year 2023 Financial and Operational Results
8:16am
8-K
bzi410819 dns0y96jm
28 Mar 24
HarborOne Bancorp, Inc. Announces 6.7% Increase in First Quarter 2024 Dividend
8:15am
8-K
abiyqz4t484ijkxcsv
28 Mar 24
China Automotive Systems Reports Record Annual Revenue, and a 81.2% Increase in Diluted Net Income Per Share to $1.25 in Fiscal Year 2023
8:06am
8-K
bxlzu8ww1j9akgkqdgof
28 Mar 24
Smartkem Reports Fourth Quarter and Full Year 2023 Financial Results
8:05am
8-K
45x8pr pe3zlo4buw
28 Mar 24
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
8:05am
8-K
tvjvdnqlj84
28 Mar 24
IMUNON Reports 2023 Financial Results and Provides Business Update
8:05am
8-K
39xhn 7n1x9j
28 Mar 24
Departure of Directors or Certain Officers
8:01am
8-K
3s00mbwt5k51
28 Mar 24
NeuroBo Pharmaceuticals Reports Year End 2023 Financial Results and Provides Corporate Update
8:01am
8-K
u55gjh1k3f4k kufn
28 Mar 24
Unregistered Sales of Equity Securities
8:01am
8-K
7fbuhij2rhm fo11tl5b
28 Mar 24
Regulation FD Disclosure
8:00am
8-K
zxka188
28 Mar 24
QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss
8:00am
8-K
yja0m
28 Mar 24
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
8:00am
8-K
cjk5lgos3abptw za
28 Mar 24
Stifel Reports February 2024 Operating Data
8:00am
8-K
dd0bu4 o0mn
28 Mar 24
Other Events
8:00am
8-K
lbs 9z3fletyzzc4v77x
28 Mar 24
Departure of Directors or Certain Officers
8:00am
8-K
dj4sjz7xw21lopbrplz
28 Mar 24
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
8:00am